OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
119
Results
Show all
Save search
Copy query
Show results for
Unknown
(114)
Proteomics
(4)
Transcriptomics
(1)
Organisms
Homo sapiens
(2)
Saccharomyces cerevisiae
(1)
Arabidopsis thaliana
(1)
Magallana gigas
(1)
Repository
pride
(3)
biostudies-arrayexpress
(2)
Tissue
Early embryonic cell
(1)
Kidney
(1)
Leaf
(1)
Plant cell
(1)
Technology Type
Mass Spectrometry
(3)
Shotgun proteomics
(2)
Gel-based experiment
(1)
SWATH MS
(1)
Publication Date
2022
(2)
2016
(1)
2015
(1)
2025
(1)
Study type
Transcription profiling by array
(1)
Proteomic profiling by array
(1)
Release Date
2024
(20)
2025
(17)
2022
(17)
2023
(13)
2021
(11)
2020
(9)
2019
(8)
2016
(7)
2018
(4)
2013
(2)
2015
(1)
2026
(1)
2014
(1)
2012
(1)
2011
(1)
2006
(1)
2005
(1)
1998
(1)
Lab affiliation
Department of Biological Sciences - University of Alberta
(1)
Laboratory Head Walter and Eliza Hall Institute of Medical Research 1G Royal Parade, Parkville, AUS 3052
(1)
Protim - Irset Inserm U1085
(1)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.
Not available
S-EPMC5341823
|
biostudies-literature
Cite
Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
Not available
S-EPMC7409181
|
biostudies-literature
Cite
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Not available
S-EPMC8314140
|
biostudies-literature
Cite
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with
RAS
-mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Not available
S-EPMC7425244
|
biostudies-literature
Cite
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Not available
S-EPMC8010802
|
biostudies-literature
Cite
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
Not available
S-EPMC6734266
|
biostudies-literature
Cite
ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.
Not available
S-EPMC11707217
|
biostudies-literature
Cite
Leiomyomatosis peritonealis disseminata in association with Currarino syndrome?
Not available
S-EPMC1481579
|
biostudies-literature
Cite
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
Not available
S-EPMC10024144
|
biostudies-literature
Cite
From Cortical and Subcortical Grey Matter Abnormalities to Neurobehavioral Phenotype of Angelman Syndrome: A Voxel-Based Morphometry Study.
Not available
S-EPMC5023118
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets